Tian Zhang: STAREV is open and enrolling UTSW Simmons Cancer Center
Tian Zhang, Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center, reshared a post by Qian Janie Qin, Assistant Professor at UT Southwestern, on X:
“STAREV is open and enrolling UTSW Simmons Cancer Center UTSW Radiation Oncology UTSW Hematology & Oncology!
Looking for localized bladder cancer to treat with EV, radiation and followed by cystectomy.”
Quoting Qian Janie Qin‘s post:
“Dr. Tian Zhang highlighting the STAREV trial of enfortumab vedotin + radiation in locally advanced, cisplatin-ineligible bladder cancer with. Dr. Neil Desai and UTSW Radiation Oncology at UTSW Simmons Cancer Center.”
Tian Zhang is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in the diagnosis and treatment of genitourinary malignancies. She has gained an international reputation developing clinical trials in kidney, prostate, and bladder cancers. She serves as the study chair for PDIGREE, a phase III trial in metastatic renal cell carcinoma. She serves on numerous committees, including as Co-chair of the National Cancer Institute Genitourinary (GU) Steering Committee Renal Task Force and as Chair of the Chinese American Hematologist and Oncologist Network (CAHON) Academic Committee. She is a member of several ASCO clinical management guidelines committees as well as the Alliance for Clinical Trials in Oncology, GU Oncology, and Immuno-Oncology Committees. She has received multiple peer-reviewed grants, a Resident Research Mentoring Award from Duke, and, notably, the 2021 Cancer Prevention & Research Institute of Texas (CPRIT) Scholar Rising Stars Award.
For more Updates, Follow OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023